Q BioMed Inc (QBIO)

[GUNSMOKE]

QBIO !! HIGH-LIGHTED !

The researchers highlight Utt-B as a promising anti-HCC drug, owing to its enhanced therapeutic efficacy and pharmacological safety over sorafenib, the first-line treatment option for HCC.

This innovation has been granted a patent from the US, Canada, Japan and South Korea and has been conferred 'Orphan Drug' status against HCC by the U.S. FDA.